Accelerate Diagnostics Files for Chapter 11 Protection
Accelerate Diagnostics has filed for Chapter 11 bankruptcy and plans to sell its assets through a court-supervised process.
Accelerate Diagnostics has filed for Chapter 11 bankruptcy and plans to sell its assets through a court-supervised process.
Innovative IVF techniques are emerging to improve implantation predictions through non-invasive, AI-driven metabolomics assays.
NeoGenomics and Ultima Genomics have partnered to use the UG 100 sequencing platform to advance precision oncology diagnostics.
Thermo Fisher has launched the 1500 Series Class II, Type A2 Biological Safety Cabinet, enhancing lab safety and operational efficiency.
A new peer-reviewed study confirms that Ibex Breast significantly enhances accuracy, speed, and efficiency of breast pathology evaluations.